Format

Send to

Choose Destination
J Hum Genet. 2019 Dec 11. doi: 10.1038/s10038-019-0701-6. [Epub ahead of print]

Reply to: "Development of an MSI-positive colon tumor with aberrant DNA methylation in a PPAP patient".

Author information

1
Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
2
Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
3
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
4
Gastrointestinal Cancer Genetics Laboratory, Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, UK.
5
Edinburgh Cancer Research Centre, IGMM, University of Edinburgh, Edinburgh, UK.
6
Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain. lvalle@idibell.cat.
7
Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain. lvalle@idibell.cat.
8
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. lvalle@idibell.cat.
PMID:
31822785
DOI:
10.1038/s10038-019-0701-6

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center